← Back to all trials
Active Not Recruiting
NCT03208387
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Conditions: Brain Tumor, Pediatric Brain Tumor, Pediatric Cancer
Sex: All
Ages: 6 Years – 16 Years
Enrollment: 42
Sponsor: Memorial Sloan Kettering Cancer Center
Location: Columbia University New York New York
Summary
The goal of this study is to learn about the cognitive and behavioral functioning of children being treated for cancer.
Eligibility Criteria
Inclusion Criteria:
Children Treated for Posterior Fossa Tumors:
* As per medical record or clinical report, successfully completed all medical treatment for either an M0 posterior fossa medulloblastoma without dissemination or posterior fossa low-grade astrocytoma without relapse or evidence of residual disease.
* For medulloblastoma survivors only: Previously treated with gross total resection (GTR), craniospinal irradiation with conformal posterior fossa boost radiotherapy (CSI + Boost) and chemotherapy
* For low grade astrocytoma survivors only: Previously treated with gross total resection ONLY (no chemotherapy or radiotherapy).
* As per medical record or clinician report, between 1-10 years post completion of their medical treatment for their posterior fossa brain tumor.
* Subject is between the ages of 6 through 16 years at time of consent.
* As per medical record or parent report, subject is able to tolerate an MRI without sedation.
Healthy Control Participants:
* No major medical illness, as determined by medical interview by study physician.
* As per parent report, subject is between the ages of 6 through 16 years at time of consent.
* As per parent report, subject is able to tolerate an MRI without sedation.
Exclusion Criteria:
All Participants:
* Full Scale IQ as documented to be below a standard score of \
Source: ClinicalTrials.gov (NCT03208387). StuddyBuddy aggregates publicly available trial information.